Fundraising Fox
Nephrogen
YC S20Techstars '25New York City, US · Founded 2022 · 5 employees · 21 known investors
Find your way into Nephrogen
Sign up to see every warm intro you have to Nephrogen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nephrogen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nephrogen develops AI-powered AAV delivery vehicles for genetic medicines targeting kidney and pancreatic diseases. The company uses high-throughput in vivo screening to design tissue-specific viral vectors that are significantly more efficient and less immunogenic than existing alternatives.
Founders & leadership· Y Combinator alumni (S20)
Nephrogen was founded in 2022 by Demetri Maxim and Demetri M..
Investors · 21
How we know: Y Combinator's founder network · chicagoearly.com · Not right? Tell us
__Twitter.png)
How we know: Y Combinator's founder network · gaingels.com · Not right? Tell us
How we know: StartX's portfolio page · Not right? Tell us
How we know: the Techstars portfolio · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us
How we know: the Y Combinator directory · Y Combinator's founder network · Not right? Tell us
How we know: press coverage · Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
Related companies · 8
Companies working in the same space as Nephrogen.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2023 | $325K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Legal entities · 1
corporate structureFrequently asked questions
- What does Nephrogen do?
- Nephrogen develops AI-powered AAV delivery vehicles for genetic medicines targeting kidney and pancreatic diseases. The company uses high-throughput in vivo screening to design tissue-specific viral vectors that are significantly more efficient and less immunogenic than existing alternatives.
- Who founded Nephrogen?
- Nephrogen was founded by Demetri Maxim, Demetri M. in 2022.
- Who are Nephrogen's investors?
- Nephrogen's investors include Chicago Early Growth Ventures (CEGV), Gaingels, Novogenia GmbH, StartX, Techstars, Y Combinator, ZAKA VC, 10X Capital and 13 more.
- Where is Nephrogen headquartered?
- Nephrogen is headquartered in New York City, US.